Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract 4406: Clinical efficacious combined chemo/immunotherapy differently activates AKT pathway and functionality of gp100 and Melan-A specific T cell clones

Belinda Palermo, Cosmo Di Donna, Ornella Franzese, Duilia Del Bello, Novella Gualtieri, Luisa Imberti, Carmen Nuzzo, Enrico Proietti, Caterina Catricalà, Virginia Ferraresi, Paola Nisticò

Cancer Res (2012) 72 (8_Supplement): 4406.

https://doi.org/10.1158/1538-7445.AM2012-4406

Published: 15 April 2012

View articletitled, Abstract 4406: Clinical efficacious combined chemo/immunotherapy differently activates AKT pathway and functionality of gp100 and Melan-A specific T cell clones

Journal Articles

Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to Cyclophosphamide

Federica Moschella, Mara Valentini, Eleonora Aricò, Iole Macchia, Paola Sestili, Maria Teresa D'Urso, Cristiano Alessandri, Filippo Belardelli, Enrico Proietti

Cancer Res (2011) 71 (10): 3528–3539.

https://doi.org/10.1158/0008-5472.CAN-10-4523

Published: 15 May 2011

View articletitled, Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to Cyclophosphamide

Includes: Supplementary data

Journal Articles

Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

Giovanna Schiavoni, Antonella Sistigu, Mara Valentini, Fabrizio Mattei, Paola Sestili, Francesca Spadaro, Massimo Sanchez, Silvia Lorenzi, Maria Teresa D'Urso, Filippo Belardelli, Lucia Gabriele, Enrico Proietti, Laura Bracci

Cancer Res (2011) 71 (3): 768–778.

https://doi.org/10.1158/0008-5472.CAN-10-2788

Published: 01 February 2011

View articletitled, Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

Includes: Supplementary data

Journal Articles

Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients

Belinda Palermo, Duilia Del Bello, Alessandra Sottini, Federico Serana, Claudia Ghidini, Novella Gualtieri, Virginia Ferraresi, Caterina Catricalà, Filippo Belardelli, Enrico Proietti, Pier Giorgio Natali, Luisa Imberti, Paola Nisticò

Cancer Res (2010) 70 (18): 7084–7092.

https://doi.org/10.1158/0008-5472.CAN-10-1326

Published: 14 September 2010

View articletitled, Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients

Includes: Supplementary data

Journal Articles

Pyrimethamine Induces Apoptosis of Melanoma Cells via a Caspase and Cathepsin Double-Edged Mechanism

Anna Maria Giammarioli, Angela Maselli, Andrea Casagrande, Lucrezia Gambardella, Angelo Gallina, Massimo Spada, Antonello Giovannetti, Enrico Proietti, Walter Malorni, Marina Pierdominici

Cancer Res (2008) 68 (13): 5291–5300.

https://doi.org/10.1158/0008-5472.CAN-08-0222

Published: 01 July 2008

View articletitled, Pyrimethamine Induces Apoptosis of Melanoma Cells via a Caspase and Cathepsin Double-Edged Mechanism

Includes: Supplementary data

Journal Articles

Chemotherapy treatment before peptide-vaccination diversifies the TCR repertoire specific for Melan-A/HLA2 in melanoma patients

Paola Nistico, Belinda Palermo, Duilia Del Bello, Novella Gualtieri, Virginia Ferraresi, Federica Moschella, Enrico Proietti, Pier Giorgio Natali, Alessandra Sottini, Claudia Ghidini, Federico Serana, Luisa Imberti

Cancer Res (2008) 68 (9_Supplement): 2543.

Published: 01 May 2008

View articletitled, Chemotherapy treatment before peptide-vaccination diversifies the TCR repertoire specific for Melan-A/HLA2 in melanoma patients

Journal Articles

Chemo-immunotherapy in melanoma patients: Dacarbazine to enhance a tumor specific CD8+ T cell response

Paola Nisticò, Pier Giorgio Natali, Duilia Del Bello, Belinda Palermo, Alessandra Ranieri, Virginia Ferraresi, Francesco Cognetti, Mariangela Ciccarese, Alessandra Felici, Mario Roselli, Emanuela Fossile, Giuseppe Vercillo, Mara Valentini, Laura Bracci, Federica Moschella, Filippo Belardelli, Imerio Capone, Enrico Proietti

Cancer Res (2006) 66 (8_Supplement): 677–678.

Published: 15 April 2006

View articletitled, Chemo-immunotherapy in melanoma patients: Dacarbazine to enhance a tumor specific CD8+ T cell response

Journal Articles

The Induction of in Vivo Proliferation of Long-Lived CD44^hi CD8⁺ T Cells after the Injection of Tumor Cells Expressing IFN-α₁ into Syngeneic Mice

Filippo Belardelli, Maria Ferrantini, Stefano M. Santini, Sara Baccarini, Enrico Proietti, Mario P. Colombo, Jonathan Sprent, David F. Tough

Cancer Res (1998) 58 (24): 5795–5802.

Published: 01 December 1998

View articletitled, The Induction of in Vivo Proliferation of Long-Lived CD44hi CD8+ T Cells after the Injection of Tumor Cells Expressing IFN-α1 into Syngeneic Mice

Journal Articles

α₁-Interferon Gene Transfer into Metastatic Friend Leukemia Cells Abrogated Tumorigenicity in Immunocompetent Mice: Antitumor Therapy by Means of Interferon-producing Cells

Maria Ferrantini, Enrico Proietti, Laura Santodonato, Lucia Gabriele, Manuela Peretti, Ivan Plavec, François Meyer, Thomas Kaido, Ion Gresser, Filippo Belardelli

Cancer Res (1993) 53 (5): 1107–1112.

Published: 01 March 1993

View articletitled, α1-Interferon Gene Transfer into Metastatic Friend Leukemia Cells Abrogated Tumorigenicity in Immunocompetent Mice: Antitumor Therapy by Means of Interferon-producing Cells

Journal Articles

Combined Interleukin 1β/Interleukin 2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression

Enrico Proietti, Elena Tritarelli, Lucia Gabriele, Ugo Testa, Giampaolo Greco, Elvira Pelosi, Marco Gabbianelli, Filippo Belardelli, Cesare Peschle

Cancer Res (1993) 53 (3): 569–576.

Published: 01 February 1993

View articletitled, Combined Interleukin 1β/Interleukin 2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression

Journal Articles

Inhibition by Mouse α/β-Interferon of the Multiplication of α/β-Interferon-resistant Friend Erythroleukemia Cells Cocultured with Mouse Hepatocytes

Hiroaki Yasui, Enrico Proietti, Françoise Vignaux, Pierre Eid, Ion Gresser

Cancer Res (1990) 50 (12): 3533–3539.

Published: 01 June 1990

View articletitled, Inhibition by Mouse α/β-Interferon of the Multiplication of α/β-Interferon-resistant Friend Erythroleukemia Cells Cocultured with Mouse Hepatocytes

Journal Articles

Nuclear Magnetic Resonance Analysis of Tumor Necrosis Factor-induced Alterations of Phospholipid Metabolites and pH in Friend Leukemia Cell Tumors and Fibrosarcomas in Mice

Franca Podo, Giulia Carpinelli, Massimo Di Vito, Massimo Giannini, Enrico Proietti, Walter Fiers, Ion Gresser, Filippo Belardelli

Cancer Res (1987) 47 (24_Part_1): 6481–6489.

Published: 15 December 1987

View articletitled, Nuclear Magnetic Resonance Analysis of Tumor Necrosis Factor-induced Alterations of Phospholipid Metabolites and pH in Friend Leukemia Cell Tumors and Fibrosarcomas in Mice

Journal Articles

³¹P-Nuclear Magnetic Resonance Analysis of Interferon-induced Alterations of Phospholipid Metabolites in Interferon-sensitive and Interferon-resistant Friend Leukemia Cell Tumors in Mice

Enrico Proietti, Giulia Carpinelli, Massimo Di Vito, Filippo Belardelli, Ion Gresser, Franca Podo

Cancer Res (1986) 46 (6): 2849–2857.

Published: 01 June 1986

View articletitled, 31P-Nuclear Magnetic Resonance Analysis of Interferon-induced Alterations of Phospholipid Metabolites in Interferon-sensitive and Interferon-resistant Friend Leukemia Cell Tumors in Mice

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 4406: Clinical efficacious combined chemo/immunotherapy differently activates AKT pathway and functionality of gp100 and Melan-A specific T cell clones

Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to Cyclophosphamide

Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients

Pyrimethamine Induces Apoptosis of Melanoma Cells via a Caspase and Cathepsin Double-Edged Mechanism

Chemotherapy treatment before peptide-vaccination diversifies the TCR repertoire specific for Melan-A/HLA2 in melanoma patients

Chemo-immunotherapy in melanoma patients: Dacarbazine to enhance a tumor specific CD8+ T cell response

The Induction of in Vivo Proliferation of Long-Lived CD44^hi CD8⁺ T Cells after the Injection of Tumor Cells Expressing IFN-α₁ into Syngeneic Mice

α₁-Interferon Gene Transfer into Metastatic Friend Leukemia Cells Abrogated Tumorigenicity in Immunocompetent Mice: Antitumor Therapy by Means of Interferon-producing Cells

Combined Interleukin 1β/Interleukin 2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression

Inhibition by Mouse α/β-Interferon of the Multiplication of α/β-Interferon-resistant Friend Erythroleukemia Cells Cocultured with Mouse Hepatocytes

Nuclear Magnetic Resonance Analysis of Tumor Necrosis Factor-induced Alterations of Phospholipid Metabolites and pH in Friend Leukemia Cell Tumors and Fibrosarcomas in Mice

³¹P-Nuclear Magnetic Resonance Analysis of Interferon-induced Alterations of Phospholipid Metabolites in Interferon-sensitive and Interferon-resistant Friend Leukemia Cell Tumors in Mice

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only